Hairgenetix combines advanced copper peptide science with clinical-grade delivery mechanisms to address hair loss at the follicular level. Our formulations are based on peer-reviewed research and validated through a 150-day clinical trial.
Written by Malcolm Smith, Founder of Hairgenetix · Medically reviewed by Dr. Esther Bodde, Cosmetic & Medical Doctor (MD) · Last updated: March 2026
Quality You Can Trust, Results You Can See
Hair mesotherapy is a treatment where biologically active ingredients — such as copper peptides (GHK-Cu, AHK-Cu) and PDRN — are delivered directly into the scalp through micro-infusion to stimulate dormant hair follicles and reduce shedding. In a 150-day clinical trial with 30 participants, the Hairgenetix serum achieved a 93% reduction in hair shedding. All products are third-party tested for purity and developed under medical advisory oversight.
Targeting hair loss with precision
At Hairgenetix, we are dedicated to revolutionizing hair care and hair growth through cutting-edge innovation. Our team of scientists and experts is committed to developing effective solutions for hair loss and hair thinning, with a mission to truly make a difference in the lives of those affected.
It all starts with fully understanding the science behind hair loss. Then bringing together the newest developments in technology & biscience to develop innovative solutions to utilize the power of nature, rather than working against it.
The hair growth cycle
A clear understanding of the entire hair growth cycle not only helps in addressing common hair concerns but also distinguishes between what is typical and what may require attention. By gaining insight into the science behind hair loss and regrowth, we can better identify and prevent the factors that may disrupt this natural cycle. Knowledge is power, and with it, we can take proactive steps to protect and nurture your hair's natural rhythm.
Micro-injections for maximum effectiveness
Mesotherapy offers a superior approach to hair care compared to traditional topical serums and derma rollers. By utilizing micro-injections, it ensures precise infusion of the hair growth serum directly into the scalp, targeting and nourishing the hair at its roots for maximum effectiveness.
The patented serum cartridge, equipped with 12 micro-needles, delivers the Advanced Hair Growth Serum directly into the scalp with exceptional precision. Designed for optimal absorption and enhanced hair growth results, the system features adjustable fluid discharge and needle depth, allowing for a tailored treatment experience that meets individual needs.
EMS micro current stimulation
The Hairgenetix mesotherapy pen also uses the latest in innovative EMS technology. The circular multi-polar Level 4 Microcurrent reaches deep into the skin and stimulates hair and skin cells and accelerates collagen synthesis. This also amplifies & enhances the effect of the Advanced Hair Growth Serum.
The Science Behind Our Ingredients
Understanding the active compounds that power Hairgenetix hair growth solutions
How copper peptides promote hair growth
Copper peptides are short chains of amino acids bound to a copper ion. The two most researched for hair growth are GHK-Cu and AHK-Cu. They work through three mechanisms:
Angiogenesis — stimulates new blood vessel formation around follicles, increasing oxygen and nutrient delivery.
Anti-inflammation — reduces pro-inflammatory cytokines (TNF-α, IL-6), protecting follicles from chronic inflammation.
Extended growth phase — activates Wnt/β-catenin pathways, extending the anagen phase and delaying regression.
A 2012 review documented GHK-Cu's ability to increase hair follicle size by up to 40%
Pickart, Vasquez-Soltero, and Margolina confirmed that copper peptides reactivate dormant follicles in both men and women, promoting angiogenesis and reducing scalp inflammation at the cellular level.
PDRN activates the adenosine A2A receptor for tissue regeneration
Clinical studies show significant improvements in tissue quality within 4–8 weeks of PDRN treatment. By promoting angiogenesis alongside copper peptides, PDRN amplifies nutrient delivery to the hair follicle.
What is PDRN and why is it in Hairgenetix?
PDRN (Polydeoxyribonucleotide) is a bioactive compound extracted from salmon DNA. It triggers three key responses in the scalp:
Tissue regeneration — promotes fibroblast proliferation and collagen synthesis, rebuilding the extracellular matrix that anchors follicles.
Scalp healing — accelerates repair of micro-damage caused by inflammation, oxidative stress, or microneedling.
Enhanced blood flow — promotes angiogenesis alongside copper peptides, amplifying nutrient delivery to follicles.
Clinical Evidence
Results from the Hairgenetix 150-day clinical trial and published peer-reviewed research
The Hairgenetix clinical trial
In a 150-day clinical trial involving 30 men and women aged 18–65 with various types of hair loss, the Hairgenetix serum achieved:
93% reduction in hair shedding (pull test)
75% of participants reported visible new growth by day 90
70% improvement in hair density (trichoscopy)
90% satisfaction rate at trial completion
All participants used the Meso-Infusion System as directed, with assessments at 30, 60, 90, 120, and 150 days under medical supervision.
Published research supporting hair mesotherapy
Pickart et al. (2012) — GHK-Cu increases follicle size, promotes angiogenesis, reactivates dormant follicles.
Dhurat et al. (2013) — Microneedling significantly improves hair count in androgenetic alopecia.
Mesotherapy Review (2023) — Systematic review confirms efficacy across multiple treatment protocols.
Copper Peptides & Hair (2019) — Copper peptides validated for stimulating hair follicle activity.
Xu et al. (2024) — Microneedling + active compounds shows superior results vs. topical-only.
How mesotherapy compares
Hair Mesotherapy (Hairgenetix) — Micro-infusion of copper peptides + PDRN directly into scalp. At-home, ~€50/month. Results in 2–4 months.
Minoxidil — Topical vasodilator, €20–40/month. Must use indefinitely; scalp irritation common.
Finasteride — Oral DHT blocker, €30–60/month. Prescription only; hormonal side effects.
Alternative treatments
PRP Therapy — Platelet-rich plasma injections, €200–500/session. Clinic only; expensive with mixed evidence.
Low-Level Laser (LLLT) — Red light stimulation, €200–800 device. Modest results; daily use required.
Hair Transplant — Surgical follicle relocation, €3,000–15,000. Invasive; limited donor hair.
Mesotherapy offers a middle ground — more targeted than topicals, less invasive than surgery, without hormonal side effects.
Frequently Asked Questions
Yes. The Hairgenetix system uses 24-karat gold micro-needles with controlled 1–2mm penetration depth, designed specifically for safe self-application. All serums are sterile, single-use vials. Follow the included instructions carefully.
Most users report reduced shedding within 4–6 weeks. Visible new growth typically appears between 2–4 months. In our clinical trial, 75% of participants saw visible improvement by day 90.
Many users combine mesotherapy with other treatments. Copper peptides work through different pathways than minoxidil (vasodilation) or finasteride (DHT blocking), so they can complement each other. Consult your doctor before combining treatments.
Our clinical trial included participants with androgenetic alopecia, telogen effluvium, and diffuse thinning. Results were positive across all types. However, mesotherapy cannot regrow hair where follicles are completely scarred (cicatricial alopecia).
The recommended protocol is once weekly for the first 3 months (intensive phase), then once every 2–4 weeks for maintenance. Each box contains 4 vials — a one-month supply during the intensive phase.
How Copper Peptide Treatment Compares
| Treatment | Evidence Level | Side Effects | Mechanism |
|---|---|---|---|
| GHK-Cu Copper Peptides | Moderate (peer-reviewed) | Minimal | Follicle regeneration via Wnt/β-catenin signalling |
| Minoxidil 5% | Strong (FDA approved) | Scalp irritation, initial shedding | Vasodilation, extends anagen phase |
| Finasteride 1mg | Strong (FDA approved) | Sexual side effects (1–2%) | DHT blocker (5α-reductase inhibitor) |
| PRP Therapy | Moderate (clinic-based) | Pain at injection site | Growth factor concentration |
References
- Dhurat R et al. (2013). Randomized evaluator blinded study of effect of microneedling in androgenetic alopecia. Int J Trichology.
- Pickart L et al. (2012). The human tripeptide GHK-Cu in prevention of oxidative stress. Int J Mol Sci.
- Pei S et al. (2024). Microneedling for androgenetic alopecia: a systematic review and meta-analysis. J Cosmet Dermatol.
- Gupta AK et al. (2022). Microneedling for hair loss. J Cosmet Dermatol.
- Gupta AK et al. (2023). Systematic review of mesotherapy for hair loss. J Dermatolog Treat.
- PDRN polynucleotide gel efficacy for pattern hair loss. (2024). Arch Dermatol Res.
Written by Malcolm Smith, Founder of Hairgenetix · Medically reviewed by Dr. Esther Bodde, Cosmetic & Medical Physician (MD) · Last updated: March 2026
References: Pickart et al. 2012 (GHK-Cu) · Mesotherapy Review 2023 · Copper Peptides & Hair 2019
